|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25,770.05 INR | -0.11% |
|
-1.92% | -11.35% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 4.31TCr | 4.92TCr | 5.35TCr | 5.85TCr | 6.41TCr | |||||
Total Assets | 3.84TCr | 4.22TCr | 4.56TCr | 5.19TCr | 5.92TCr | |||||
Interest Expense | -15Cr | -15Cr | -12Cr | -8.88Cr | -7.1Cr | |||||
Income Tax Expense | 235.26Cr | 281.03Cr | 324.41Cr | 416.53Cr | 472.51Cr | |||||
CAPEX | -23Cr | -44Cr | -34Cr | -48Cr | -53Cr | |||||
EBT | 925.95Cr | 1.08TCr | 1.27TCr | 1.62TCr | 1.89TCr | |||||
D&A | 57Cr | 66Cr | 70Cr | 71Cr | 72Cr | |||||
Net Income | 690.69Cr | 798.7Cr | 949.41Cr | 1.2TCr | 1.41TCr |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
outside India | - | - | - | - | - | |||||
Export | - | - | - | - | - | |||||
India | - | - | - | - | - |
- Stock Market
- Equities
- ABBOTINDIA Stock
- Financials Abbott India Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition